| 发明名称 |
ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING RUXOLITINIB |
| 摘要 |
The invention essentially relates to oral dosage forms comprising a JAK kinase inhibitor, preferably Ruxolitinib, suitable for modified release, and processes of preparing such oral dosage forms. |
| 申请公布号 |
WO2014016396(A1) |
申请公布日期 |
2014.01.30 |
| 申请号 |
WO2013EP65771 |
申请日期 |
2013.07.25 |
| 申请人 |
RATIOPHARM GMBH |
发明人 |
STEFAN, RALPH;SIEVERT, FRANK |
| 分类号 |
A61K9/20;A61K9/48;A61K31/4045;A61K31/519 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
